Anti-CSK Purified

*Palomero T, Couronné L, Khiabanian H, Kim MY, Ambesi-Impiombato A, Perez-Garcia A, Carpenter Z, Abate F, Allegretta M, Haydu JE, Jiang X, Lossos IS, Nicolas C, Balbin M, Bastard C, Bhagat G, Piris MA, Campo E, Bernard OA, Rabadan R, Ferrando AA: Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet. 2014 Feb;46 (2) :166-70. , URL: https://www.ncbi.nlm.nih.gov/pubmed/24413734

*Liang F, Luo Y, Dong Y, Walls CD, Liang J, Jiang HY, Sanford JR, Wek RC, Zhang ZY: Translational Control of C-terminal Src Kinase (Csk) Expression by PRL3 Phosphatase. J Biol Chem. 2008 Apr 18;283 (16) :10339-46., URL: https://www.ncbi.nlm.nih.gov/pubmed/18268019?ordin, *Ingley E: Src family kinases: regulation of their activities, levels and identification of new pathways. Biochim Biophys Acta. 2008 Jan;1784 (1) :56-65., URL: https://www.ncbi.nlm.nih.gov/pubmed/17905674?ordin, *Takayama Y, Tanaka S, Nagai K, Okada M: Adenovirus-mediated overexpression of C-terminal Src kinase (Csk) in type I astrocytes interferes with cell spreading and attachment to fibronectin. Correlation with tyrosine phosphorylations of paxillin and FAK. J Biol Chem. 1999 Jan 22;274 (4) :2291-7., URL: https://www.ncbi.nlm.nih.gov/pubmed/9890993?ordina, *Bergman M, Joukov V, Virtanen I, Alitalo K: Overexpressed Csk tyrosine kinase is localized in focal adhesions, causes reorganization of alpha v beta 5 integrin, and interferes with HeLa cell spreading. Mol Cell Biol. 1995 Feb;15 (2) :711-22., URL: https://www.ncbi.nlm.nih.gov/pubmed/7529872?ordina, *Chow LM, Fournel M, Davidson D, Veillette A: Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk. Nature. 1993 Sep 9;365 (6442) :156-60., URL: https://www.ncbi.nlm.nih.gov/pubmed/8371758?ordina, *Sabe H, Okada M, Nakagawa H, Hanafusa H: Activation of c-Src in cells bearing v-Crk and its suppression by Csk. Mol Cell Biol. 1992 Oct;12 (10) :4706-13., URL: https://www.ncbi.nlm.nih.gov/pubmed/1383688?ordina